Cargando…
Can the anti-inflammatory activities of β2-agonists be harnessed in the clinical setting?
Beta2-adrenoreceptor agonists (β2-agonists) are primarily bronchodilators, targeting airway smooth muscle and providing critical symptomatic relief in conditions such as bronchial asthma and chronic obstructive pulmonary disease. These agents also possess broad-spectrum, secondary, anti-inflammatory...
Autores principales: | Theron, Annette J, Steel, Helen C, Tintinger, Gregory R, Feldman, Charles, Anderson, Ronald |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3840775/ https://www.ncbi.nlm.nih.gov/pubmed/24285920 http://dx.doi.org/10.2147/DDDT.S50995 |
Ejemplares similares
-
The Beta-2-Adrenoreceptor Agonists, Formoterol and Indacaterol, but Not Salbutamol, Effectively Suppress the Reactivity of Human Neutrophils In Vitro
por: Anderson, Ronald, et al.
Publicado: (2014) -
Formoterol is more effective than salmeterol in suppressing neutrophil reactivity
por: Tintinger, Gregory R., et al.
Publicado: (2015) -
Pathogen- and Host-Directed Anti-Inflammatory Activities of Macrolide Antibiotics
por: Steel, Helen C., et al.
Publicado: (2012) -
Pharmacological control of neutrophil-mediated inflammation: Strategies targeting calcium handling by activated polymorphonuclear leukocytes
por: Tintinger, Gregory R, et al.
Publicado: (2009) -
Montelukast: More than a Cysteinyl Leukotriene Receptor Antagonist?
por: Tintinger, Gregory R., et al.
Publicado: (2010)